For example, pioglitazone, a potent insulin sensitizer, has been proven to reduce cardiovascular complications in patients without diabetes who had IR along with a recent history of ischemic stroke or transient ischemic attack [36]. The gene discussed is INS; the disease is diabetes mellitus.